Skip to main content

Essure Devices Discontinued As Per FDA's Guidelines

Essure Devices Discontinued As Per FDA's Guidelines

Essure Devices Discontinued As Per FDA's Guidelines

Introduction

The Food & Drug Administration of the U.S. indicated that all the Essure devices are removed from the market, and the women who had permanently implanted the device are enrolled in a study to evaluate the risk associated with it.

99% of the devices were successfully retrieved from the market by Bayer, and only 10 units are remaining. Besides retrieving the devices, Bayer will study 340 women who implanted the device and compare the results to 788 women who were about to undergo laparoscopic tubal ligation.

The Essure device is used for birth control, but thousands of women suffered complications, including migration injuries, perforation, severe reactions, and other problems, which resulted in the removal of the devices from the market.

Essure is suspended from the market in most of the countries since 2017, but Bayer continued to sell the device in the U.S. until the end of 2018. In July 2018, Bayer announced to remove all the Essure devices from the U.S. market from December 2018.

Bayer is currently facing 18,000 lawsuits nationwide. Worldwide 750,000 women have been implanted with the device, of which 70% are from the U.S. as estimated by Bayer.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!